International Cancer Imaging Society

International Cancer Imaging Society Meeting and 15th Annual Teaching Course

Mon 05 Oct 2015 - Wed 07 Oct 2015

Clore Education Centre, British Museum, London, UK

Targeting cancer with imaging 

Royal College of Radiologists: 18 category 1 points

Registration is now open, click here to reserve your place. Further information can be found here.

Submit your abstract here.

» Other Meetings

Interactive Workshops

Masterclass in Imaging of Gynaecological Cancers

Mon 11 May 2015  

Stockholm, Sweden

These one day teaching courses are limited to 40 participants, each with their own imaging workstation and content delivered through lectures and hands-on case based learning.


» Register now! 

Cancer Imaging Journal

Cancer Imaging is the official journal of ICIS, it is an open access, peer-reviewed journal with original articles as well as reviews and editorials.  The journal encompasses CT, MRI, ultrasound, single photon and positron emission tomography, including multimodality imaging in all kinds of malignant tumours, plus new developments, techniques and innovations.

About ICIS

The International Cancer Imaging Society exists to meet the important challenges of advancing imaging in the multidisciplinary management of cancer.

We promote education in oncological imaging and stimulate research in the study of human tumour behaviour, bringing together radiologists with an interest in oncological imaging for the exchange of ideas, and to organise scientific meetings, multicentre research studies and postgraduate courses within the field.



» President's Message 

Join our Society

Do you believe that Cancer Imaging is important?

If your answer is yes, join us to support and promote the education in oncological imaging and stimulate research in the study of human tumour behaviour.

As a member you will also receive:

  • Discounted registration fees for all our teaching courses
  • Exclusive access to the members' area
  • Exclusive access to posters and presentations from the annual teaching course
  • 15% off the APC for submitting manuscripts to Cancer Imaging

» Join now 

Registration opens for London 2015
27 February 2015

Registration opens for London 2015

Prof. Andrea Rockall, President for 2015 has put together a really exciting programme for our annual teaching course.  

Keynote lectures
Microbubbles: From cancer diagnosis to theranostics
MR/PET imaging: Future directions

Plenary sessions
Structured reporting and decision support

» Read more

As a Radiologist who focuses on Cancer Imaging, I find ICIS courses and meetings extremely useful and stimulating. Not only do I get to meet the doyens in the field, the courses and meetings are so rich in state of art technology and new developments in the field of cancer imaging. There is no other imaging conference, that gives me so much value for the time.

BP | Australia

I am so glad I came to ICIS. It was an excellent meeting with very interesting topics and with excellent facilities.  It is always a pleasure to attend ICIS as it is an ideal meeting to interact with people from many countries and to learn about new skills in oncology imaging and novel techniques. You always choose beautiful places for ICIS and we hope to come again next year to London for another wonderful meeting.

MN | Argentina

I am so very happy I came to ICIS this year, my first time.  Some of the talks were truly “life changing”.  I will gladly try to implement things I heard into my daily practice.  This conference showed me again what an exciting job I have and that here at ICIS I can acquire tools to truly make a difference.  Thank you!  Becoming a member of ICIS is a must!

EP | Germany

Register your interest for all ICIS interactive courses

Please click on the link below to register your interest for future ICIS interactive courses.  We will notify you in advance of registration opening, allowing you first refusal on this popular range of courses.

To register your interest, fill in the details below and click on the "Register Interest" button.

Subscribe to our mailing list

* indicates required
Email Format

Cancer / Oncology News From Medical News Today

Ovary removal linked with 62% reduction in BRCA1-related breast cancer deaths

Published: Sat, 25 Apr 2015 07:00:00 GMT

The benefits of oophorectomy, the procedure to remove the ovaries, are confirmed in a new study published in JAMA Oncology that examines survival among breast cancer patients.

TLR5 genetic variants may predict antitumor responses to entolimod

Published: Fri, 24 Apr 2015 09:00:00 GMT

Roswell Park Cancer Institute (RPCI) researchers examined the characteristics of genetic variants in human toll-like receptor 5 (TLR5), and have found that these genetic variants may predict...

Genomic analyses point to the potential of personalised care for liver cancer patients

Published: Fri, 24 Apr 2015 09:00:00 GMT

A new study presented at The International Liver Congress 2015 shows that by using genomic analyses to understand how and when carcinogenic mutations occur in patients with hepatocellular carcinoma...

Transgene announces new pre-clinical data for two of its programs - TG4010 and TG3003

Published: Fri, 24 Apr 2015 09:00:00 GMT

Transgene SA has announced that new pre-clinical data for two of its programs - TG4010 and TG3003 - were presented at the Annual Meeting of the American Association for Cancer Research (AACR) in...

FACC-29 gathers authenticated canine cancer cell lines for research and drug development

Published: Fri, 24 Apr 2015 08:00:00 GMT

New resource helps animal cancer researchers catch contaminated cellsMuch of what we know about cancer and many modern medicines that treat it grow from experiments on cancer cells.

Personalized cancer treatment

Published: Fri, 24 Apr 2015 08:00:00 GMT

How to identify drugs that work best for each patientMore than 100 drugs have been approved to treat cancer, but predicting which ones will help a particular patient is an inexact science at best.

Microinjection platform tests multiple cancer drugs in tumors, predicts systemic response

Published: Fri, 24 Apr 2015 08:00:00 GMT

Data published in Science Translational Medicine show positive findings using patented new technology with multiple cancer drugs tested in xenografted mouse models, canine patients, first-in-human...

Childhood cancer survivors more likely to claim social security support as adults

Published: Fri, 24 Apr 2015 07:00:00 GMT

Children with cancer have a good chance of surviving the disease--today more than 80 percent survive because of advances in treatment and care.

Mayo Clinic researchers identify methylated DNA markers -- noninvasive cancer screen

Published: Fri, 24 Apr 2015 07:00:00 GMT

A team of Mayo Clinic researchers has succeeded in identifying the source of cancer in patients' gastrointestinal tracts by analyzing DNA markers from tumors.

Coffee 'could halve breast cancer recurrence' in tamoxifen-treated patients

Published: Thu, 23 Apr 2015 15:00:00 GMT

Consuming at least two cups of coffee a day could halve the risk of recurrence in patients diagnosed with breast cancer who are treated with tamoxifen, according to a new study.

The Association for Molecular Pathology compiles current research on liquid biopsy

Published: Thu, 23 Apr 2015 09:00:00 GMT

The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, has published a special article in The Journal of Molecular...

Inflammation-cancer feedback loop discovery is a step toward better cancer drugs

Published: Thu, 23 Apr 2015 09:00:00 GMT

New findings hidden within the complex machinery behind the vicious cycle of chronic inflammation and cancer have been presented by researchers from the University of Pittsburgh Cancer Institute...

Investigational brain cancer vaccine produces strong immunological response

Published: Thu, 23 Apr 2015 09:00:00 GMT

A first-of-its kind cancer vaccine, SurVaxM, has demonstrated safety and tolerability in patients with recurrent or progressive malignant brain tumors, according to results of a phase I study...

UF Health Proton Therapy Institute opens randomized clinical trial for glioblastoma

Published: Thu, 23 Apr 2015 09:00:00 GMT

Adults who have a recent diagnosis of glioblastoma, the most common primary brain tumor, may be eligible to enroll in a national randomized clinical trial at the University of Florida Health Proton...

When genes are expressed in reverse: Discovered a regulatory mechanism of antisense DNA

Published: Thu, 23 Apr 2015 08:00:00 GMT

Genes are nearly alwaya expressed like Western writing: from left to right on the white canvas of our DNA.

Pruning of blood vessels: Cells can fuse with themselves

Published: Thu, 23 Apr 2015 07:00:00 GMT

Cells of the vascular system of vertebrates can fuse with themselves. This process, which occurs when a blood vessel is no longer necessary and pruned, has now been described on the cellular level by...

Tonsillectomy in childhood to prevent tonsillitis may reduce the risk for HPV-related tonsil cancer

Published: Wed, 22 Apr 2015 09:00:00 GMT

Undergoing prophylactic childhood tonsillectomy reduced the future risk for tonsil carcinoma diagnosis, according to the results of a study published in Cancer Prevention Research, a journal of the...

Cancer gene unintentionally ends the life of cancer cells, turns off life supporting genes

Published: Wed, 22 Apr 2015 09:00:00 GMT

A new study from the University of Wurzburg, Germany and the University of Helsinki, Finland, suggests that Myc cancer gene makes cells to commit suicide by repressing life supporting "well-being"...

REVLIMID (lenalidomide) now available in UK for adult patients with previously untreated multiple myeloma who are not eligible for transplant

Published: Wed, 22 Apr 2015 09:00:00 GMT

Celgene Limited, a wholly owned subsidiary of Celgene Corporation, has announced that REVLIMID (lenalidomide) is now available for adult patients with previously untreated multiple myeloma who are...

Cancer diagnosis leads to higher quit rates among smokers

Published: Wed, 22 Apr 2015 08:00:00 GMT

The largest study of its kind to date finds smokers diagnosed with cancer were more likely to quit than other smokers, supporting the hypothesis that a cancer diagnosis is a "teachable moment" that...